Molecular neurobiology of dopaminergic receptors
Abstract
Table I summarizes the properties of all of the dopamine receptors that have been cloned to date. Thus far, five different genes encoding pharmacologically distinct receptors have been identified and isolated. Based on their structural, pharmacological, and functional similarities, two of these, D1A and D1B (or D1 and D5), comprise the D1 subfamily. D2, D3, and D4 receptors represent a D2 subfamily whose members are also structurally and pharmacologically similar. In fact, given these considerations, it has been suggested that the D2, D3, and D4 receptors be termed the D2A, D2B, and D2C receptors, respectively, in recognition of their D2-like properties. Given the unexpected heterogeneity of the dopaminergic receptor system, it is logical to ask if there are other dopamine receptor subtypes remaining be identified. This seems probable, as the characteristics of the cloned subtypes do not match all of the properties of some dopamine receptors which have been previously investigated. For instance, there is extensive evidence that "D1-like" dopamine receptors exist which are linked to the activation of phospholipase C, phosphatidylinositol turnover, and Ca2+ mobilization. Dopamine, as well as several "D1-selective" agonists, has been shown to stimulate phosphatidylinositol turnover in both brain slices and kidney membranes (Felder et al., 1989; Undie and Friedman, 1990; Vyas et al., 1992), and injection of striatal mRNA into Xenopus oocytes leads to dopamine-stimulated phosphatidylinositol turnover and Ca2+ mobilization (Mahan et al., 1990). These dopamine receptors might be analogous to the alpha 1-adrenergic receptors which stimulate phospholipase C activity and might define a third distinct subfamily of dopamine receptors. There is also evidence for additional members of the D2 subfamily of receptors. Using gene transfer methods, a receptor with D2-like pharmacology has been identified and expressed but not yet sequenced (Todd et al., 1989). Also, a D2-related receptor has been characterized in kidney inner medulla membranes (Huo et al., 1991). It thus appears that there may be more dopamine receptor subtypes yet to be discovered.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dopaminergic neuron actions are mediated by GPCRs, which range from D1 to D5.
“Dopaminergic neuron actions are mediated by GPCRs, which range from D1 to D5 (Sibley et al., 1993).”
From Convergence of oxytocin and dopamine signalling in neuronal circuits: Insights into the neurobiology of social interactions across species (2024) · cites this paper as Sibley et al., 1993
Cites
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967 · see citing works
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608 · see citing works
Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015 · see citing works
Bunney, W. E., Hippius, H., Laakmann, G., & Schmauß, M. (1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3 · Cited by 1,523 · see citing works
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J. W., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,377 · see citing works
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Sunahara, R. K., Guan, H., O’Dowd, B. F., Seeman, P. M., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Tol, H. H. M. V., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,166 · see citing works
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P. R., Salon, J. A., Christie, M. J., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,116 · see citing works
Bouthenet, M.-L., Souil, E., Martres, M., Sokoloff, P., Bruno Giros, A., & Schwartz, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91456-b · Cited by 868 · see citing works
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
Bruno Giros, A., Sokoloff, P., Martres, M., Riou, J., Emorine, L. J., & Schwartz, J.-C. (1989) · Nature · doi:10.1038/342923a0 · Cited by 685 · see citing works
Molecular cloning and expression of the gene for a human D1 dopamine receptor
Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Bates, M. D., & Caron, M. G. (1990) · Nature · doi:10.1038/347072a0 · Cited by 674 · see citing works
Multiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641 · see citing works
The dopamine D2 receptor: two molecular forms generated by alternative splicing.
Toso, R. D., Sommer, B., Ewert, M., Herb, A., Pritchett, D. B., Bach, A., Shivers, B. D., & SEEBURG, P. H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08585.x · Cited by 600 · see citing works
Cloning and expression of human and rat Dt dopamine receptors
Zhou, Q., Grandy, D. K., Thambi, L., Kushner, J. A., Tol, H. H. M. V., Cone, R. D., Pribnow, D. G., Salon, J. A., Bunzow, J. R., & Civelli, O. (1990) · Nature · doi:10.1038/347076a0 · Cited by 562 · see citing works
D1 and D2 dopamine receptor mRNA in rat brain.
Weiner, D. M., Levey, A. I., Sunahara, R. K., Niznik, H. B., O’Dowd, B. F., Seeman, P. M., & Brann, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1859 · Cited by 491 · see citing works
Cloning of the cDNA and gene for a human D2 dopamine receptor.
Grandy, D. K., Marchionni, M. A., Makam, H., Stofko, R. E., Alfano, M., Frothingham, L., Fischer, J., Burke-Howie, K. J., Bunzow, J. R., & Server, A. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9762 · Cited by 486 · see citing works
Structural basis of β‐adrenergic receptor function
Strader, C. D., Sigal, I. S., & Dixon, R. A. F. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.7.2541037 · Cited by 481 · see citing works
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
Weiner, D. M., Levey, A. I., & Brann, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7050 · Cited by 481 · see citing works
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.
Moine, C. L., Normand, E., & Bloch, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4205 · Cited by 472 · see citing works
Dopamine receptor gene expression by enkephalin neurons in rat forebrain.
Moine, C. L., Normand, E., Guitteny, A. F., Fouqué, B., Teoule, R., & Bloch, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.230 · Cited by 470 · see citing works
Mansour, A., Meador‐Woodruff, J. H., Bunzow, J., Civelli, O., Akil, H., & Watson, S. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02587.1990 · Cited by 467 · see citing works
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5
Sunahara, R. K., Niznik, H. B., Weiner, D. M., Stormann, T. M., Brann, M. R., Kennedy, J. L., Gelernter, J. E., Rozmahel, R. F., Yang, Y., Israel, Y., et al. (1990) · Nature · doi:10.1038/347080a0 · Cited by 462 · see citing works
Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation.
Monsma, F. J., Mahan, L. C., McVittie, L. D., Gerfen, C. R., & Sibley, D. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6723 · Cited by 456 · see citing works
Grandy, D. K., Litt, M. J., Allen, L., Bunzow, J. R., Marchionni, M. A., Makam, H., Reed, L., Magenis, R. E., & Civelli, O. (1989) · PubMed · Cited by 421 · see citing works
Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M., Bruno Giros, A., & Schwartz, J.-C. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90107-7 · Cited by 401 · see citing works
Tiberi, M., Jarvie, K. R., Silvia, C. P., Falardeau, P., Gingrich, J. A., Godinot, N., Bertrand, L., Yang-Feng, T. L., Fremeau, R. T., & Caron, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7491 · Cited by 359 · see citing works
Fremeau, R. T., Duncan, G. E., Fornaretto, M. G., Dearry, A., Gingrich, J. A., Breese, G. R., & Caron, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3772 · Cited by 354 · see citing works
Mechanisms of signal transduction at the dopamine D2 receptor
Vallar, L., & Meldolesi, J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90082-5 · Cited by 313 · see citing works
Dopamine receptor subtypes: beyond the D1/D2 classification
Andersen, P. H., Gingrich, J. A., Bates, M. D., Dearry, A., Falardeau, P., Senogles, S. E., & Caron, M. G. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90249-8 · Cited by 293 · see citing works
Distribution of D2 dopamine receptor mRNA in rat brain.
Meador‐Woodruff, J. H., Mansour, A., Bunzow, J. R., Tol, H. H. M. V., Watson, S. J., & Civelli, O. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7625 · Cited by 261 · see citing works
Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism
Piomelli, D., Pilon, C., Bruno Giros, A., Sokoloff, P., Martres, M., & Schwartz, J.-C. (1991) · Nature · doi:10.1038/353164a0 · Cited by 258 · see citing works
Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain.
Meador‐Woodruff, J. H., Mansour, A., Healy, D. J., Kuehn, R., Zhou, Q., Bunzow, J. R., Akil, H., Civelli, O., & Watson, S. J. (1991) · PubMed · Cited by 242 · see citing works
Vallar, L., Muca, C., Magni, M., Albert, P. R., Bunzow, J. R., Meldolesi, J., & Civelli, O. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86948-4 · Cited by 234 · see citing works
Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
Undie, A. S., & Friedman, E. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13248-5 · Cited by 217 · see citing works
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes.
Grandy, D. K., Zhang, Y. A., Bouvier, C., Zhou, Q. Y., Johnson, R. A., Allen, L., Buck, K. J., Bunzow, J. R., Salon, J. A., & Civelli, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9175 · Cited by 209 · see citing works
Mahan, L. C., Burch, R. M., Monsma, F. J., & Sibley, D. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2196 · Cited by 206 · see citing works
D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum
Moine, C. L., Tison, F., & Bloch, B. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90671-u · Cited by 197 · see citing works
The third dopamine receptor (D3) as a novel target for antipsychotics
Sokoloff, P., Martres, M., Bruno Giros, A., Bouthenet, M.-L., & Schwartz, J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90227-a · Cited by 191 · see citing works
Neve, K. A., Cox, B., Henningsen, R. A., Spanoyannis, A., & Neve, R. L. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11081-x · Cited by 189 · see citing works
Mengod, G., Martinez-Mir, M. I., Vilaró, M. T., & Palacios, J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8560 · Cited by 164 · see citing works
Albert, P. R., Neve, K. A., Bunzow, J. R., & Civelli, O. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39945-4 · Cited by 147 · see citing works
A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus
Chio, C. L., Hess, G. F., Graham, R. S., & Huff, R. M. (1990) · Nature · doi:10.1038/343266a0 · Cited by 142 · see citing works
Bruno Giros, A., Martres, M., Pilon, C., Sokoloff, P., & Schwartz, J.-C. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90469-n · Cited by 138 · see citing works
The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS
Gelernter, J. E., Kennedy, J. L., Tol, H. H. M. V., Civelli, O., & Kídd, K. K. (1992) · Genomics · doi:10.1016/0888-7543(92)90222-e · Cited by 128 · see citing works
Kanterman, R. Y., Mahan, L. C., Briley, E. M., Monsma, F. J., Sibley, D. R., Axelrod, J., & Felder, C. C. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10960-7 · Cited by 126 · see citing works
Weinshank, R. L., Adham, N., Macchi, M., Olsen, M. A., Branchek, T. A., & Hartig, P. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54590-7 · Cited by 124 · see citing works
Montmayeur, J., & Borrelli, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3135 · Cited by 112 · see citing works
O’Malley, K. L., Mack, K. J., Gandelman, K., & Todd, R. D. (1990) · Biochemistry · doi:10.1021/bi00458a003 · Cited by 107 · see citing works
The distribution of a dopamine D2 receptor mRNA in rat brain
Weiner, D. M., & Brann, M. R. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80960-3 · Cited by 102 · see citing works
Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation.
Neve, K. A., Neve, R. L., Fidel, S., Janowsky, A. J., & Higgins, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2802 · Cited by 101 · see citing works
Visualization of a dopamine D1 receptor mRNA in human and rat brain
Mengod, G., Vilaró, M. T., Niznik, H. B., Sunahara, R. K., Seeman, P. M., O’Dowd, B. F., & Palacios, J. M. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90110-j · Cited by 101 · see citing works
Differential expression of the mouse D2 dopamine receptor isoforms
Montmayeur, J., Bausero, P., Amlaiky, N., Maroteaux, L., Hen, R., & Borrelli, E. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80125-m · Cited by 99 · see citing works
The Major Dopamine D2 Receptor: Molecular Analysis of the Human D2 A Subtype
SELBIE, L. A., Hayes, G. R., & Shine, J. (1989) · DNA · doi:10.1089/dna.1.1989.8.683 · Cited by 91 · see citing works
Felder, C. C., Williams, H. L., & Axelrod, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6477 · Cited by 90 · see citing works
Characterization of the 5' flanking region of the human D1A dopamine receptor gene.
Minowa, M. T., Minowa, T., Monsma, F. J., Sibley, D. R., & Mouradian, M. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3045 · Cited by 89 · see citing works
Analysis of the Structure and Expression of the Human Dopamine D2A Receptor Gene
Gandelman, K., Harmon, S., Todd, R. D., & O’Malley, K. L. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02024.x · Cited by 77 · see citing works
Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.
Neve, K. A., Henningsen, R. A., Bunzow, J. R., & Civelli, O. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09326-5 · Cited by 74 · see citing works
Molecular cloning and expression of a dopamine D2 receptor from human retina.
Stormann, T. M., Gdula, D. C., Weiner, D. M., & Brann, M. R. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09942-0 · Cited by 74 · see citing works
McVittie, L. D., Ariano, M. A., & Sibley, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1441 · Cited by 67 · see citing works
Alternative transcripts of the rat and human dopamine D3 receptor
Snyder, L., Roberts, J. L., & Sealfon, S. C. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81169-6 · Cited by 63 · see citing works
Vyas, S. J., Eichberg, J., & Lokhandwala, M. F. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11200-7 · Cited by 54 · see citing works
Human dopamine D5 receptor pseudogenes
Nguyen, T., Bard, J., Jin, H., Taruscio, D., Ward, D. C., Kennedy, J. L., Weinshank, R. L., Seeman, P. M., & O’Dowd, B. F. (1991) · Gene · doi:10.1016/0378-1119(91)90611-e · Cited by 50 · see citing works
Cloning of two additional catecholamine receptors from rat brain
O’Dowd, B. F., Nguyen, T., Tirpak, A., Jarvie, K. R., Israel, Y., Seeman, P. M., & Niznik, H. B. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80140-e · Cited by 49 · see citing works
Najlerahim, A., BARTON, A. J. L., Harrison, P. J., Heffernan, J. M., & Pearson, R. C. A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81116-0 · Cited by 45 · see citing works
Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction
Rao, D. D., McKelvy, J., Kebabian, J. W., & MacKenzie, R. G. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80695-f · Cited by 44 · see citing works
Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA
Moine, C. L., & Bloch, B. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90086-d · Cited by 44 · see citing works
Mack, K. J., Todd, R. D., & O’Malley, K. L. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08221.x · Cited by 42 · see citing works
Todd, R. D., Khurana, T. S., Sajovic, P., Stone, K. R., & O’Malley, K. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10134 · Cited by 41 · see citing works
Snyder, L., Roberts, J. L., & Sealfon, S. C. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90187-x · Cited by 41 · see citing works
Characterization of a dopamine receptor (DA2K) in the kidney inner medulla.
Huo, T.-L., Ye, M. Q., & Healy, D. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3170 · Cited by 39 · see citing works
Transcription of a human dopamine D5 pseudogene
Nguyen, T., Sunahara, R. K., Marchese, A., Tol, H. H. M. V., Seeman, P. M., & O’Dowd, B. F. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81375-0 · Cited by 36 · see citing works
Eidne, K. A., TAYLOR, P. L., Zabavnik, J., Saunders, P. T. K., & Inglis, J. D. (1989) · Nature · doi:10.1038/342865a0 · Cited by 34 · see citing works
Eubanks, J. H., Altherr, M. R., Wagner-McPherson, C., McPherson, J. D., Wasmuth, J. J., & Evans, G. A. (1992) · Genomics · doi:10.1016/0888-7543(92)90442-u · Cited by 30 · see citing works
McChesney, R. E., Sealfon, S. C., Tsutsumi, M., Dong, K.-W., Roberts, J. L., & Bancroft, C. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90110-e · Cited by 30 · see citing works
Identification by sequence analysis of a second rat brain cDNA encoding the dopamine (D2) receptor
Miller, J. C., Wang, Y., & Filer, D. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91917-h · Cited by 27 · see citing works
MacLennan, A. J., Frantz, G. D., Weatherwax, R. C., Tillakaratne, N. J. K., & Tobin, A. J. (1990) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(90)90020-5 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A neuropsychological theory of positive affect and its influence on cognition.
Ashby, F. G., Isen, A. M., & Turken, A. U. (1999) · Psychological Review · doi:10.1037/0033-295x.106.3.529 · Cited by 2,270 · see citing works
The Neuroscience of Drug Reward and Addiction
Volkow, N. D., Michaelides, M., & Baler, R. (2019) · Physiological Reviews · doi:10.1152/physrev.00014.2018 · Cited by 863 · see citing works
Xu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90557-6 · Cited by 484 · see citing works
Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart‐Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03470.1998 · Cited by 447 · see citing works
The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus
Chang, F., Kídd, K. K., Livak, K. J., PAKSTIS, A. J., & Kídd, K. K. (1996) · Human Genetics · doi:10.1007/s004390050166 · Cited by 438 · see citing works
Kelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Sáez, C., Bunzow, J. R., Allen, R. G., Hnasko, R. M., Ben‐Jonathan, N., Grandy, D. K., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80351-7 · Cited by 425 · see citing works
Forbes, E. E., Brown, S. M., Kimak, M., Ferrell, R. E., Manuck, S. B., & Hariri, A. R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002086 · Cited by 408 · see citing works
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385 · see citing works
Smiley, J. F., Levey, A. I., Ciliax, B. J., & Goldman‐Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5720 · Cited by 383 · see citing works
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 373 · see citing works
Tarazi, F. I., & Baldessarini, R. J. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00108-2 · Cited by 327 · see citing works
Self, D. W., Genova, L. M., Hope, B. T., Barnhart, W. J., Spencer, J. J., & Nestler, E. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01848.1998 · Cited by 325 · see citing works
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307 · see citing works
“The DA D1like receptors (including D1R and D5R) are excitatory and have a low affinity for DA, meaning they respond primarily to high DA concentrations occurring during phasic firing of dopaminergic neurons (Sibley et al. 1993; Missale et al. 1998; Dreyer et al. 2010).”
Relapse to drug-seeking: neural and molecular mechanisms
Self, D. W., & Nestler, E. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00065-9 · Cited by 296 · see citing works
Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A., & Borrelli, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02977.2002 · Cited by 234 · see citing works
Zhang, L., Lou, D., Jiao, H., Zhang, D., Wang, X., Xia, Y., Zhang, J., & Xu, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-04.2004 · Cited by 224 · see citing works
Anderson, S. M., & Pierce, R. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.12.004 · Cited by 200 · see citing works
Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions
Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M., & Sankoorikal, E.-B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08305.2000 · Cited by 195 · see citing works
Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking
Schmidt, H. D., Anderson, S. M., Famous, K. R., Kumaresan, V., & Pierce, R. C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.068 · Cited by 170 · see citing works
Behavioral characterization of dopamine D-sub-5 receptor null mutant mice.
Holmes, A., Hollon, T. R., Gleason, T., Liu, Z., Dreiling, J. L., Sibley, D. R., & Crawley, J. N. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.5.1129 · Cited by 166 · see citing works
The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation
Fitsanakis, V. A., Au, C., Erikson, K. M., & Aschner, M. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.10.012 · Cited by 162 · see citing works
11. The effects of positive affect and arousal on working memory and executive attention
Ashby, F. G., Valentin, V. V., & Turken, A. U. (2002) · Advances in consciousness research · doi:10.1075/aicr.44.11ash · Cited by 155 · see citing works
Xu, M., Guo, Y. H., Vorhees, C. V., & Zhang, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02258-1 · Cited by 144 · see citing works
Dopamine Selectively Induces Migration and Homing of Naive CD8+ T Cells via Dopamine Receptor D3
Watanabe, Y., Nakayama, T., Nagakubo, D., Hieshima, K., Jin, Z. H., Katou, F., Hashimoto, K., & Yoshie, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.848 · Cited by 136 · see citing works
Dopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 130 · see citing works
Holmes, A., Lachowicz, J. E., & Sibley, D. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.034 · Cited by 133 · see citing works
Role of dopamine in the physiology of T-cells and dendritic cells
Pacheco, R., Prado, C. E., Barrientos, M. J., & Bernales, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.018 · Cited by 129 · see citing works
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
Prado, C. E., Contreras, F., Velozo, H. G., Díaz, P., Elgueta, D., Barrientos, M. J., Herrada, A. A., Lladser, Á., Bernales, S., & Pacheco, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103096 · Cited by 132 · see citing works
Neural substrates of drug craving and relapse in drug addiction
Self, D. W. (1998) · Annals of Medicine · doi:10.3109/07853899809029938 · Cited by 130 · see citing works
Mizoguchi, H., Yamada, K., Mizuno, M., Mizuno, T., Nitta, A., Noda, Y., & Nabeshima, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1293 · Cited by 130 · see citing works
Chen, Y., Wang, S., Xu, X., Liu, X., Yu, M., Zhao, S., Liu, S., Qiu, Y., Zhang, T., Liu, B., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400408r · Cited by 129 · see citing works
Pharmacology of signaling induced by dopamine D1-like receptor activation
Undieh, A. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.003 · Cited by 128 · see citing works
Bongarzone, E. R., Howard, S. G., Schonmann, V., & Campagnoni, A. T. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05344.1998 · Cited by 127 · see citing works
Nakano, K., Yamaoka, K., Hanami, K., Saito, K., Sasaguri, Y., Yanagihara, N., Tanaka, S., KATSUKI, I., Matsushita, S., & Tanaka, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002475 · Cited by 123 · see citing works
Chronic cocaine‐mediated changes in non‐human primate nucleus accumbens gene expression
Freeman, W. M., Nader, M. A., Nader, S. H., Robertson, D. J., Gioia, L., Mitchell, S. M., Daunais, J. B., Porrino, L. J., Friedman, D. P., & Vrana, K. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00252.x · Cited by 122 · see citing works
Anderson, S. M., Schmidt, H. D., & Pierce, R. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300922 · Cited by 112 · see citing works
Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical
Baldessarini, R. J., & Tarazi, F. I. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017200 · Cited by 112 · see citing works
Dopamine receptor D3 deficiency results in chronic depression and anxiety
Moraga‐Amaro, R., Gonzalez, H., Pacheco, R., & Stehberg, J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.055 · Cited by 106 · see citing works
Graff‐Guerrero, A., Willeit, M., Ginovart, N., Mamo, D. C., Mizrahi, R., Rusjan, P., Vitcu, I., Seeman, P. M., Wilson, A. A., & Kapur, S. (2007) · Human Brain Mapping · doi:10.1002/hbm.20392 · Cited by 107 · see citing works
Brain‐derived neurotrophic factor regulates the expression of D1 dopamine receptors
Do, T., Kerr, B., & Kuzhikandathil, E. V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04249.x · Cited by 100 · see citing works
Schmidt, H. D., & Pierce, R. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.004 · Cited by 94 · see citing works
Obadiah, J. M., Avidor‐Reiss, T., Fishburn, C. S., Carmon, S., Bayewitch, M. L., Vogel, Z., Fuchs, S., & Levavi‐Sivan, B. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006988603199 · Cited by 94 · see citing works
Panchalingam, S., & Undie, A. S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00011-9 · Cited by 92 · see citing works
Repeated Cocaine Administration Induces Gene Expression Changes through the Dopamine D1 Receptors
Zhang, D., Zhang, L., Tang, Y., Zhang, Q., Lou, D., Sharp, F. R., Zhang, J., & Xu, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300680 · Cited by 89 · see citing works
Deveney, A. M., & Waddington, J. L. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16420.x · Cited by 89 · see citing works
Filip, M., Frankowska, M., Zaniewska, M., Przegaliński, E., Müller, C. E., Agnati, L. F., Franco, R., Roberts, D. C. S., & Fuxé, K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.038 · Cited by 87 · see citing works
Dopamine D-5 receptor modulates hippocampal acetylcholine release
Hersi, A. I., Kitaichi, K., Srivastava, L. K., Gaudreau, P., & Quirion, R. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00015-2 · Cited by 85 · see citing works
Nann-Vernotica, E., Donny, E. C., Bigelow, G. E., & WALSH, S. L. (2001) · Psychopharmacology · doi:10.1007/s002130100724 · Cited by 83 · see citing works
Sebastianutto, I., Maslava, N., Hopkins, C. R., & Cenci, M. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.001 · Cited by 83 · see citing works
Park, K., Volkow, N. D., Pan, Y., & Du, C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1935-13.2013 · Cited by 79 · see citing works
Hard target: Understanding dopaminergic neurotransmission
Nestler, E. J. (1994) · Cell · doi:10.1016/0092-8674(94)90022-1 · Cited by 78 · see citing works
NGB 2904 and NGB 2849: Two highly selective dopamine D3 receptor antagonists
Yuan, J., Chen, X., Brodbeck, R. M., Primus, R. J., Braun, J., Wasley, J. W. F., & Thurkauf, A. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00469-7 · Cited by 75 · see citing works
Heckman, P. R. A., Blokland, A., Bollen, E., & Prickaerts, J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.007 · Cited by 75 · see citing works
Positron emission tomography imaging studies of dopamine receptors in primate models of addiction
Nader, M. A., Czoty, P. W., Gould, R. W., & Riddick, N. V. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0092 · Cited by 74 · see citing works
Compounds selective for dopamine receptor subtypes
Kebabian, J. W., Tarazi, F. I., Kula, N. S., & Baldessarini, R. J. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01075-1 · Cited by 72 · see citing works
Kawano, M., Takagi, R., Kaneko, A., & Matsushita, S. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.001 · Cited by 68 · see citing works
Enhanced reward-related responding following cholera toxin infusion into the nucleus accumbens
Kelley, A. E., & Holahan, M. R. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199705)26:1 · Cited by 31 · see citing works
Kumar, T. P., Antony, S., Gireesh, G., George, N., & Paulose, C. S. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-43 · Cited by 68 · see citing works
Richtand, N. M., Kelsoe, J. R., Segal, D. S., & Kuczenski, R. T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00112-6 · Cited by 65 · see citing works
Wilke, R. A., Lupardus, P. J., Grandy, D. K., Rubinstein, M., Low, M. J., & Jackson, M. B. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00391.x · Cited by 63 · see citing works
Elgueta, D., Aymerich, M. S., Contreras, F., Montoya, A., Celorrio, M., Rojo-Bustamante, E., Riquelme, E., González, H., Vásquez, M., Franco, R., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.028 · Cited by 61 · see citing works
Debnath, M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9626-9 · Cited by 60 · see citing works
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 60 · see citing works
A role of RGS proteins in drug addiction
Hooks, S. B., Martemyanov, K. A., & Zachariou, V. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.045 · Cited by 61 · see citing works
Neuromodulation in Polycystic Ovary Syndrome
Kalro, B. N., Loucks, T. L., & Berga, S. L. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70184-4 · Cited by 60 · see citing works
The role of tissue plasminogen activator in methamphetamine‐related reward and sensitization
Nagai, T., Noda, Y., Ishikawa, K., Miyamoto, Y., Yoshimura, M., Ito, M., Takayanagi, M., Takuma, K., Yamada, K., & Nabeshima, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02903.x · Cited by 60 · see citing works
Jiao, H., Zhang, L., Gao, F., Lou, D., Zhang, J., & Xu, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04840.x · Cited by 59 · see citing works
Neuroendocrine Immunoregulation in Multiple Sclerosis
Deckx, N., Lee, W.-P., Berneman, Z. N., & Cools, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/705232 · Cited by 59 · see citing works
Nair, M., Mahajan, S. D., Schwartz, S. A., Reynolds, J. L., Whitney, R., Bernstein, Z., Chawda, R. P., Sykes, D., Hewitt, R. G., & Hsiao, C. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6617 · Cited by 56 · see citing works
PDE and cognitive processing: Beyond the memory domain
Heckman, P. R. A., Blokland, A., Ramaekers, J. G., & Prickaerts, J. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.10.011 · Cited by 55 · see citing works
Pacheco, R., Riquelme, E. M., & Kalergis, A. M. (2010) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152410790780154 · Cited by 54 · see citing works
Amino Acid Side Chains That Define Muscarinic Receptor/G-protein Coupling
Burstein, E. S., Spalding, T. A., & Brann, M. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2882 · Cited by 55 · see citing works
Yamaguchi, H., Aiba, A., Nakamura, K. D., Nakao, K., Sakagami, H., Goto, K., Kondo, H., & Katsuki, M. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.d01-238.x · Cited by 53 · see citing works
Treatment of neurolept-induced tardive dyskinesia
Jankelowitz, S. K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s30767 · Cited by 52 · see citing works
Zarrindast, M., Bananej, M., Khalilzadeh, A., Fazli‐Tabaei, S., HAERIROHANI, A., & Rezayof, A. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.04.002 · Cited by 52 · see citing works
Rappeneau, V., & Castillo Díaz, F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105675 · Cited by 51 · see citing works
“Dopaminergic neuron actions are mediated by GPCRs, which range from D1 to D5 (Sibley et al., 1993).”
BackgroundDopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
Olivares-Hernández, A., Figuero-Pérez, L., Cruz, J. J., González‐Sarmiento, R., Usategui‐Martín, R., & Miramontes‐González, J. P. (2021) · Biomolecules · doi:10.3390/biom11020254 · Cited by 51 · see citing works
Demane, D. F., Contreras, F., González, H., Prado, C. E., Elgueta, D., Figueroa, C. A., & Pacheco, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.003 · Cited by 49 · see citing works
DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls
Adamson, M. D., Kennedy, J. L., Petronis, A., Dean, M. C., Virkkunen, M. E., Linnoila, M., & Goldman, D. A. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600306 · Cited by 49 · see citing works
S-(+)-aporphines are not selective for human D3 dopamine receptors
Kula, N. S., Baldessarini, R. J., Kebabian, J. W., & Neumeyer, J. L. (1994) · Cellular and Molecular Neurobiology · doi:10.1007/bf02090784 · Cited by 47 · see citing works
Mori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 47 · see citing works
Chang, F., Ko, H., Lu, R., PAKSTIS, A. J., & Kídd, K. K. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00248-x · Cited by 47 · see citing works
Prado, C. E., Gaiazzi, M., González, H., Ugalde, V., Figueroa, A., Osorio‐Barrios, F., López, E., Lladser, Á., Rasini, E., Marino, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00571 · Cited by 46 · see citing works
Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang, Y., Qiu, A.-W., Peng, Y.-P., Liu, Y., Huang, H., & Qiu, Y. (2010) · PubMed · Cited by 46 · see citing works
Quinpirole-induced 50kHz ultrasonic vocalization in the rat: Role of D2 and D3 dopamine receptors
Brudzyński, S. M., Komadoski, M., & Pierre, J. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.004 · Cited by 45 · see citing works
Ricci, L. A., Schwartzer, J. J., & Melloni, R. H. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.10.011 · Cited by 43 · see citing works
Mikulak, J., Bozzo, L., Roberto, A., Pontarini, E., Tentorio, P., Hudspeth, K. L., Lugli, E., & Mavilio, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401114 · Cited by 44 · see citing works
Sweitzer, M. M., Donny, E. C., & Hariri, A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.01.017 · Cited by 48 · see citing works
Synthesis and characterization of selective dopamine D2 receptor antagonists
Vangveravong, S., McElveen, E., Taylor, M., Xu, J., Tu, Z., Luedtke, R. R., & Mach, R. H. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.008 · Cited by 44 · see citing works
Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease
Cardinale, A., & Fusco, F. R. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12834 · Cited by 43 · see citing works
Zhen, X., Zhang, J., Johnson, G., & Friedman, E. (2001) · PubMed · Cited by 43 · see citing works
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis
Ferreira, T. B., Barros, P. O., Teixeira, B., Cassano, T., Centurião, N., Kasahara, T. M., Hygino, J., Vasconcelos, C. C. F., Filho, H. A., Alvarenga, R. M. P., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.013 · Cited by 41 · see citing works
O'Sullivan, G. J., Kinsella, A., Sibley, D. R., Tighe, O., Croke, D. T., & Waddington, J. L. (2005) · Synapse · doi:10.1002/syn.20107 · Cited by 42 · see citing works
Ortinski, P. I., Briand, L. A., Pierce, R. C., & Schmidt, H. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.002 · Cited by 40 · see citing works
Gould, R. W., Duke, A. N., & Nader, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.004 · Cited by 39 · see citing works
Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder
Ferreira, T. B., Kasahara, T. M., Barros, P. O., Vieira, M. M. M., Bittencourt, V. C. B., Hygino, J., Andrade, R. M., Linhares, U. C., Andrade, A. F., & Bento, C. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.009 · Cited by 40 · see citing works
Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function
Wang, Y., Berndt, T. J., Gross, J. M., Peterson, M. A., So, M. J., & Knox, F. G. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.1.r248 · Cited by 40 · see citing works
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5
Jeon, H.-M., Oh, Y. T., Shin, Y. J., Chang, N., Kim, D., Woo, D., Yeup, Y., Joo, K. M., Jo, H., Yang, H., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100894 · Cited by 40 · see citing works
Hristova, A. H., & Koller, W. C. (2000) · Drugs & Aging · doi:10.2165/00002512-200017030-00002 · Cited by 38 · see citing works
- Authors
- Sibley, D. R., Monsma, F. J., & Shen, Y.
- Affiliations
- National Institutes of Health (US)
- Venue
- International review of neurobiology
- Publisher
- Elsevier
- Published
- 1993
- Volume
- 35
- Pages
- 391-415
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W1671798294
- Cited by
- 255
- References
- 75
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 7 · 2020: 1 · 2019: 1 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 10 · 2014: 8 · 2013: 13 · 2012: 10
- FWCI
- 9.74
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- International review of neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine receptors, dopamine receptor subtypes, D1-like receptors, D2-like receptors, receptor cloning, phospholipase C, phosphatidylinositol turnover, calcium mobilization, striatum, kidney inner medulla, receptor heterogeneity
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Nervous System Physiological Phenomena, Receptors, Dopamine, Receptors, Dopamine D1, Receptors, Dopamine D2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review